Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allopregnanolone is a neuroactive steroid and a metabolite of progesterone. It functions primarily as a potent positive allosteric modulator of GABA_A receptors, enhancing inhibitory neurotransmission in the central nervous system. It exhibits anxiolytic, sedative, and anticonvulsant properties, and it plays a role in neurogenesis. Dysregulation of allopregnanolone levels or sensitivity is implicated in mood disorders, particularly postpartum depression and stress-induced psychiatric conditions, making it a therapeutic target for these disorders.
Positive allosteric modulator of GABA_A receptors, enhancing GABAergic inhibition by increasing chloride ion influx. Can directly activate GABA_A receptors at high concentrations.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allopregnanolone (ALLO).